Mason Carrico Analyst Performance

Research Analyst at Stephens

Mason Carrico is a stock analyst at Stephens in the medical sector, covering 16 publicly traded companies. Over the past year, Mason Carrico has issued 19 stock ratings, including buy and hold recommendations. While full access to Mason Carrico's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mason Carrico's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Analyst Rating

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

25 Last 3 Years

Buy Recommendations

84.00% 21 Buy Ratings

Companies Covered

16 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	84.0%	21 ratings
Hold	16.0%	4 ratings
Sell	0.0%	0 ratings

Out of 25 total stock ratings issued by Mason Carrico at Stephens, the majority (84.0%) have been Buy recommendations, followed by 16.0% Hold.

Best & Worst Calls

• Best Call

  000.0%

  VCYT

  Mar 2022

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  DMTK

  Jan 2022

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	16 companies

Mason Carrico, an analyst at Stephens, currently covers 16 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 16 companies	100.0%

Mason Carrico of Stephens specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 8 companies	50.0%
MEDICAL SERVICES 3 companies	18.8%
MED INSTRUMENTS 3 companies	18.8%
MEDICAL INFO SYS 1 company	6.3%
MEDICAL LABORATORIES 1 company	6.3%

About Mason Carrico

Mason is a research analyst covering the diagnostics and medical technologies sector. Mason holds a Master of Finance degree from Tulane University where he graduated Beta Gamma Sigma from the Freeman School of Business and a B.A. in Molecular, Cellular, and Developmental Biology from the University of Colorado at Boulder.

Follow on LinkedIn

Mason Carrico's Ratings History at Stephens

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
NEO NeoGenomics	9/2/2025	Boost Price Target	$8.78	$11.00	Overweight	$0.00 00.00% ROI
NTRA Natera	8/15/2025	Reiterated Rating	$158.44	$183.00	Overweight	$0.00 00.00% ROI
VCEL Vericel	6/16/2025	Reiterated Rating	$42.96	$67.00	Overweight	$0.00 00.00% ROI
ILMN Illumina	5/20/2025	Reiterated Rating	$82.95	$105.00	Overweight	$0.00 00.00% ROI
PACB Pacific Biosciences of California	5/15/2025	Reiterated Rating	$1.10	$1.80	Overweight	$0.00 00.00% ROI
TXG 10x Genomics	5/15/2025	Reiterated Rating	$9.15	$14.00	Overweight	$0.00 00.00% ROI
HOLX Hologic	5/13/2025	Lower Price Target	$57.32	$70.00	Overweight	$0.00 00.00% ROI
CDNA CareDx	5/5/2025	Reiterated Rating	$15.00	$40.00	Overweight	$0.00 00.00% ROI
VCYT Veracyte	3/26/2025	Reiterated Rating	$32.68	$45.00	Overweight	$0.00 00.00% ROI
GH Guardant Health	3/26/2025	Reiterated Rating	$46.39	$55.00	Overweight	$0.00 00.00% ROI
OCX OncoCyte	3/25/2025	Reiterated Rating	$3.10	$4.00	Equal Weight	$0.00 00.00% ROI
AKYA Akoya Biosciences	3/25/2025	Reiterated Rating	$1.62	$1.80	Equal Weight	$0.00 00.00% ROI
CTKB Cytek Biosciences	3/19/2025	Reiterated Rating	$4.32	$6.00	Overweight	$0.00 00.00% ROI
AKYA Akoya Biosciences	3/18/2025	Reiterated Rating	$1.52	$3.50	Overweight	$0.00 00.00% ROI
ILMN Illumina	3/11/2025	Reiterated Rating	$87.08	$156.00	Overweight	$0.00 00.00% ROI
CDNA CareDx	2/27/2025	Reiterated Rating	$21.81	$40.00	Overweight	$0.00 00.00% ROI
PACB Pacific Biosciences of California	2/14/2025	Reiterated Rating	$1.69	$2.50	Overweight	$0.00 00.00% ROI
HOLX Hologic	2/6/2025	Reiterated Rating	$67.44	$84.00	Overweight	$0.00 00.00% ROI
MYGN Myriad Genetics	1/16/2025	Reiterated Rating	$12.40	$20.00	Equal Weight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.